Harvard Pilgrim Health Care Home
  HPHConnect
 
  Learn more.
  Sign up for HPHConnect.
Medical Management
E-Transactions
HPHConnect
Pharmacy
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Newsroom
Office Support
Products
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
 
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

September 2016

Synagis for Upcoming RSV Season


With respiratory syncytial virus (RSV) season approaching, Harvard Pilgrim would like to remind providers of our policy regarding Synagis (palivizumab), an injection of antibodies used to protect high-risk infants from severe RSV disease. Harvard Pilgrim will be using the same prior authorization and distribution process for Synagis during the 2016-2017 RSV season as we did last season.

Synagis requires prior authorization and should be reserved for infants with a history of pre-term birth, and children with chronic lung disease or congenital heart disease. For members who qualify to receive five doses, the first dose is typically administered at the beginning of November and the last dose at the beginning of March, in order to provide protection into April.

Clinicians may order Synagis for their Harvard Pilgrim patients by faxing the Synagis Medication Request Form to Magellan Rx Pharmacy at 800-327-4561. For further details, please refer to our Synagis Clinical Coverage Criteria. If the prior authorization criteria are met, Magellan Rx Pharmacy will ship approved orders directly to clinicians’ offices and will bill Harvard Pilgrim.

For more information, please visit the Pharmacy section of Harvard Pilgrim’s provider website or call Clinical Pharmacy Services at 617-509-1786.

Email this article to a colleague   


Network Matters Archives

Download printer-friendly version

HPHCURRENT EVENTS

Improvements to the Corrected Claim and Second-Level Appeals Processes

Home Base Offers Resources and Trainings for Treating Veterans

CLINICIAN CORNER

Updated Policy: Fecal DNA Testing for Colorectal Cancer

New Coverage Reflects Importance of Advance Care Planning

Updated Policy: Vaccine and Immunization

New Policy: Monitored Anesthesia Care for GI endoscopy

Prior Authorization Required for Lipitor

Synagis for Upcoming RSV Season

Anxiety and School Refusal in Children

OFFICE ASSISTANT

Reminder for Medicare Providers: Sign Up to Use the Stride Portal

Bill Diagnosis Codes in the Primary Position for Preventive Services

PUBLICATION INFORMATION

Eric H. Schultz,
President and Chief Executive Officer

Robert Farias,
Vice President, Network Services

Annmarie Dadoly,
Editor

Joseph O'Riordan,
Writer

Kristin Edmonston,
Production Coordinator